Viking Global Investors

Activity from announced rounds

Activity in this selectionapandion-capital-cf49afaa
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$309.5M
3 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1
Undisclosed1

By primary sector

Healthtech2
Biotech1

By country

United States3

Rounds

3 in this selection
Pearl Health

Provides an AI platform for healthcare providers to manage risk and improve care for Medicare patients

$110MEquity+Debt
Role not disclosed
GT Medical Technologies

Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors

$100MSeries E
Role not disclosed
City Therapeutics

Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas

$99.5MSeries B
Role not disclosed